EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $97,933 | -3.2% | 3,452 | -0.3% | 0.00% | 0.0% |
Q4 2022 | $101,194 | +4.3% | 3,462 | -5.8% | 0.00% | 0.0% |
Q3 2022 | $97,000 | -43.3% | 3,675 | -4.3% | 0.00% | -66.7% |
Q2 2022 | $171,000 | -20.5% | 3,842 | -11.5% | 0.00% | +50.0% |
Q1 2022 | $215,000 | -4.9% | 4,342 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $226,000 | -16.9% | 4,442 | -9.0% | 0.00% | -33.3% |
Q3 2021 | $272,000 | +30.1% | 4,883 | 0.0% | 0.00% | +50.0% |
Q2 2021 | $209,000 | +2.5% | 4,883 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $204,000 | -8.5% | 4,883 | +2.1% | 0.00% | -33.3% |
Q4 2020 | $223,000 | +29.7% | 4,783 | +17.8% | 0.00% | 0.0% |
Q3 2020 | $172,000 | -11.8% | 4,059 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $195,000 | +4.3% | 4,059 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $187,000 | -23.4% | 4,059 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $244,000 | +1.2% | 4,059 | -4.7% | 0.00% | 0.0% |
Q3 2019 | $241,000 | +3.9% | 4,259 | +2.4% | 0.00% | 0.0% |
Q2 2019 | $232,000 | +7.9% | 4,159 | -2.3% | 0.00% | 0.0% |
Q1 2019 | $215,000 | +28.0% | 4,259 | +1.8% | 0.00% | 0.0% |
Q4 2018 | $168,000 | – | 4,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |